Interest Grows in Treatment of Mood Disorders by Classic Psychedelics

ABSTRACT

The article offers a perspective on the growing interest in the treatment of mood disorders with psychedelic drugs. It describes the mechanism of action of psychedelic drugs. An overview of the results of a randomized clinical trial on the efficacy of psilocybin compared with escitalopram for major depressive disorder is provided. It discusses ethical considerations for the psychedelic-assisted therapy and offers a look into the expansion of psychedelic research into other areas of psychiatry.